Genitourinary Cancers Symposium 2016

African Americans With RCC Maintain Inferior Survival in Targeted Therapy Era

African Americans With RCC Maintain Inferior Survival in Targeted Therapy Era

By

Various genomic differences in African American patients with clear cell renal cell carcinoma predict for reduced responsiveness.

RCC Samples With Higher Entropy Associated With Favorable Prognosis

RCC Samples With Higher Entropy Associated With Favorable Prognosis

By

Renal cell carcinoma samples with higher entropy, a measure of evenness and diversity, were associated with favorable prognosis.

RCC: Survival Benefit of Nivolumab Found Regardless of Baseline Factors

RCC: Survival Benefit of Nivolumab Found Regardless of Baseline Factors

By

A steady overall survival and objective response rate benefit with nivolumab vs everolimus was observed across baseline factors.

Score Accurately Predicts Presence of Adherent Perinephric Fat in Kidney Cancer

Score Accurately Predicts Presence of Adherent Perinephric Fat in Kidney Cancer

By

Risk score that can accurately predict the presence of adherent perinephric fat (APF) in patients with small renal masses.

Study Evaluates 2 Fractionation Schedules for Low-risk Prostate Cancer

Study Evaluates 2 Fractionation Schedules for Low-risk Prostate Cancer

By

A study presented at the Genitourinary Cancers Symposium evaluated two different fractionation schedules suitable for low-risk prostate cancer.

Researchers Compare Hypofractionated High-dose IMRT Schedules in Prostate Cancer

Researchers Compare Hypofractionated High-dose IMRT Schedules in Prostate Cancer

By

A recent study examined the efficacy of differing high-dose IMRT schedules on prostate cancer treatment.

Adjuvant Bicalutamide During, After Salvage RT for Localized Prostate Cancer

Adjuvant Bicalutamide During, After Salvage RT for Localized Prostate Cancer

By

Anti-androgen therapy during and after salvage radiotherapy in patients with localized prostate cancer significantly improved long-term overall survival.

Celecoxib Plus Zoledronic Acid May Improve Survival in Metastatic Prostate Cancer

Celecoxib Plus Zoledronic Acid May Improve Survival in Metastatic Prostate Cancer

By

The addition of zoledronic acid and celecoxib increases survival for men with hormone therapy-naïve metastatic prostate cancer.

Study Evaluates Role of Cytoreductive Nephrectomy in RCC With Venous Tumor Thrombus

Study Evaluates Role of Cytoreductive Nephrectomy in RCC With Venous Tumor Thrombus

By

Survival in stage IV breast cancer is improving, notably so in some patients treated initially with surgery.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs